Court halts Colorado price cap on Amgen's blockbuster Enbrel

RegulatoryEnbrelPositive

AI Analysis

Summary

A US District Court judge granted Amgen's preliminary injunction to stop Colorado's 70% price cap on Enbrel, citing potential economic injury to the company. The ruling represents a legal victory for Amgen in defending against state-level drug price controls.

Outcome Details

US District Court Judge Daniel Domenico granted Amgen's preliminary injunction to halt Colorado's 70% price cap on Enbrel

Importance:6/10

Sentiment:

0.70

pricingregulatorylitigationprice controlsEnbrelColorado

Related Companies

$AMGN

Read the original article

Published by Endpoints News on July 2, 2026 3:57 PM

Read Original